Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer

被引:0
|
作者
Sabnis, Ram W. [1 ]
机构
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 08期
关键词
D O I
10.1021/acsmedchemlett.4c00342
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Provided herein are novel KRAS inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer, and processes for preparing such compounds.
引用
收藏
页码:1201 / 1202
页数:2
相关论文
共 50 条
  • [1] Novel KRAS Inhibitors for Treating Non-Small-Cell Lung Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 773 - 774
  • [2] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [4] Nivolumab for treating non-small cell lung cancer
    Guibert, Nicolas
    Mazieres, Julien
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1789 - 1797
  • [5] Cetuximab for treating non-small cell lung cancer
    Mazzarella, Luca
    Guida, Alessandro
    Curigliano, Giuseppe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (04) : 483 - 493
  • [6] Frequency of KRAS Subtypes in Non-Small Cell Lung Cancer
    Biernacka, Anna
    Tsongalis, Peter D.
    Peterson, Jason D.
    de Abreu, Francine
    Black, Candice C.
    Gutmann, Edward
    Liu, Xiaoying
    Padmanabhan, Vijayalakshmi
    Tafe, Laura J.
    Amos, Christopher I.
    Tsongalis, Gregory J.
    MODERN PATHOLOGY, 2016, 29 : 451A - 451A
  • [7] Current perspectives of KRAS in non-small cell lung cancer
    Harris, Ethan
    Thawani, Rajat
    CURRENT PROBLEMS IN CANCER, 2024, 51
  • [8] Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Walia, Preet
    Labbe, Catherine
    Jao, Kevin
    Leighl, Natasha B.
    ONCOLOGIST, 2016, 21 (12): : 1450 - 1460
  • [9] Progress and Challenges in Non-small Cell Lung Cancer and Colorectal Cancer With Pan-KRAS Inhibitors
    Riess, Jonathan W.
    ONCOLOGY-NEW YORK, 2020, 34 (11): : 508 - 512
  • [10] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
    Li, Yunchang
    Hu, Lanlin
    Peng, Xinhao
    Xu, Huasheng
    Tang, Bo
    Xu, Chuan
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 129 - 146